siRNA treatment decreases triglycerides in individuals along with rare problem

.RESEARCH FEATURE.19 September 2024.

Plozasiran minimized triglyceride degrees through 80% and decreased the danger of pancreatitis in clients along with persistent chylomicronemia, with or without a hereditary medical diagnosis.